Keyphrases
1-deoxynojirimycin
25%
Acetamido
12%
Alkaloids
28%
Alkyl
19%
Amides
9%
Asymmetric Synthesis
12%
Azepane
16%
Azetidine
13%
Bicyclol
11%
Biological Activity
11%
Biological Evaluation
20%
Calystegines
28%
Competitive Inhibitor
12%
Cyclic Nitrones
15%
Fagomine
10%
Fluorinated
9%
Fucosidase
10%
Gaucher Disease
13%
Glucocerebrosidase
14%
Glucosidase
57%
Glucuronolactone
10%
Glycogen Phosphorylase
9%
Glycosidase
49%
Glycosidase Inhibition
63%
Glycosidase Inhibitors
28%
Hyacinthacine
13%
Hydroxymethyl
9%
IC50
19%
IC50 Value
20%
Imino
39%
Iminosugars
100%
Inhibitory Activity
28%
Maltase
11%
Mannitol
12%
Mannosidase
11%
Methyl
16%
Natural Products
11%
Pharmacological Chaperone
23%
Polyhydroxylated
24%
Potent Inhibitor
35%
Pyrrolidine
28%
Pyrrolizidine
11%
Selective Inhibitor
10%
Side Chain
11%
Stereoisomers
19%
Sucrase
10%
Synthetic Evaluation
16%
Total Synthesis
16%
α-glucosidase Inhibitor
25%
β-Galactosidase (β-Gal)
34%
Pharmacology, Toxicology and Pharmaceutical Science
1-Deoxynojirimycin
22%
Acetic Acid Derivative
6%
Acetylglucosaminidase
7%
Aldehyde Reductase
6%
Alpha Glucosidase
15%
Alpha Levo Fucosidase
12%
Amino Acid
11%
Arabinitol
10%
Azetidine
11%
Beta Glucuronidase
7%
Beta N Acetylhexosaminidase
9%
Biological Activity
11%
Carboxamide
10%
Carboxylate
7%
Castanospermum
6%
Competitive Inhibitor
10%
Convolvulaceae
5%
Fagomine
6%
Galactose
6%
Galactosidase
36%
Gaucher's Disease
11%
Glucosidase
84%
Glucosylceramidase
18%
Glycogen Phosphorylase
11%
Glycosidase
57%
Glycosidase Inhibitor
15%
Glycoside
11%
Hyperglycemia
7%
IC50
39%
Iminosugar
80%
Lysosome Storage Disease
5%
Mannitol
13%
Mannosidase
6%
Miglitol
8%
Morus
6%
Natural Product
20%
Nitrone
17%
Oxaliplatin
5%
Pharmacological Chaperone
23%
Piperidine
5%
Proline
8%
Pyrrolidine Derivative
36%
Pyrrolizidine
11%
Pyrrolizidine Alkaloid
6%
Scilla
6%
Sorbitol
8%
Structure Activity Relationship
17%
Sucrase
9%
Swainsonine
8%
Trehalase
9%